Comparison of the Duration of Effect of Metoprolol and a Sustained Release Formulation of Metoprolol (betaloc-SA)

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1981 May 1

PMID 7272165

Citations 8

Authors

D W Harron

R G Shanks

Affiliations

Soon will be listed here.

Citing Articles

Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

Alavijeh M, Chishty M, Qaiser M, Palmer A NeuroRx. 2006; 2(4):554-71.

PMID: 16489365 PMC: 1201315. DOI: 10.1602/neurorx.2.4.554.

Comparative pharmacological and pharmacokinetic observations on propranolol (long acting formulation) and bendrofluazide administered separately and concurrently to volunteers.

Nicholls D, Harron D, Mcainsh J, Castle W, Barker N, Shanks R Br J Clin Pharmacol. 1982; 14(5):727-32.

PMID: 7138752 PMC: 1427478. DOI: 10.1111/j.1365-2125.1982.tb04964.x.

Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.

Freestone S, Silas J, Lennard M, Ramsay L Br J Clin Pharmacol. 1982; 14(5):713-8.

PMID: 7138751 PMC: 1427486. DOI: 10.1111/j.1365-2125.1982.tb04962.x.

The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.

Mucklow J, Kuhn S Eur J Clin Pharmacol. 1984; 27(3):269-73.

PMID: 6510453 DOI: 10.1007/BF00542158.

Slow release beta-adrenoceptor blocking drugs.

Harron D, Howe A, Shanks R J R Coll Physicians Lond. 1983; 17(2):126-32.

PMID: 6132994 PMC: 5370928.

References

ERVIK M . Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacol Toxicol (Copenh). 1975; 36(Suppl 5):136-44. DOI: 10.1111/j.1600-0773.1975.tb03330.x. View

Degen P, RIESS W . Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography. J Chromatogr. 1976; 121(1):72-5. DOI: 10.1016/s0021-9673(00)82299-2. View

Brown H, Carruthers S, Kelly J, McDevitt D, Shanks R . Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol. 1976; 09(5-6):367-72. DOI: 10.1007/BF00606550. View

Brown H, Carruthers S, Johnston G, Kelly J, Mcainsh J, McDevitt D . Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther. 1976; 20(5):524-34. DOI: 10.1002/cpt1976205524. View

Dreyfuss J, BRANNICK L, Vukovich R, Shaw J, Willard D . Metabolic studies in patients with nadolol: oral and intravenous administration. J Clin Pharmacol. 1977; 17(5-6):300-7. DOI: 10.1002/j.1552-4604.1977.tb04609.x. View

Reybrouck T, Amery A, Fagard R, Jousten P, Lijnen P, MEULEPAS E . Beta-blockers: once or three times a day?. Br Med J. 1978; 1(6124):1386-8. PMC: 1604739. DOI: 10.1136/bmj.1.6124.1386. View

Johnsson G, Jordo L, Lundborg P, Regardh C, Ronn O . Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers. Int J Clin Pharmacol Ther Toxicol. 1980; 18(7):292-7. View

Quaterman C, Kendall M, Welling P . Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation. Eur J Clin Pharmacol. 1979; 15(2):97-103. DOI: 10.1007/BF00609871. View

Leahey W, Neill J, Varma M, Shanks R . Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. Br J Clin Pharmacol. 1980; 9(1):33-40. PMC: 1429930. DOI: 10.1111/j.1365-2125.1980.tb04793.x. View

10.

Kendall M, John V, Quarterman C, Welling P . A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. Eur J Clin Pharmacol. 1980; 17(2):87-92. DOI: 10.1007/BF00562615. View

11.

Leahey W, Neill J, Varma M, Shanks R . Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur J Clin Pharmacol. 1980; 17(6):419-24. DOI: 10.1007/BF00570158. View

12.

FRICK M, Kala R . Once daily versus twice daily beta-blockers: effects on arrhythmias and hypertension. Lancet. 1980; 2(8194):588. DOI: 10.1016/s0140-6736(80)92020-6. View

13.

Baber N, Lee A . Once daily propranolol in the treatment of mild to moderate hypertension: a dose range finding study. Eur J Clin Pharmacol. 1978; 14(3):163-6. DOI: 10.1007/BF02089954. View